The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Davies, Michael John, Dr
    Chief Executive Office born in March 1962
    Individual (10 offsprings)
    Officer
    2016-11-08 ~ now
    OF - Director → CIF 0
    Dr Michael John Davies
    Born in March 1962
    Individual (10 offsprings)
    Person with significant control
    2016-11-08 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 2
    NOVA GROUP HOLDINGS LIMITED - now
    GALACTIC HQ LTD - 2020-05-15
    LIVEWIRE 09 LTD - 2017-05-11
    Deepbridge House Honeycomb East, Chester Business Park, Chester, United Kingdom
    Liquidation Corporate (2 parents, 128 offsprings)
    Equity (Company account)
    10,937,474 GBP2022-04-05
    Officer
    2024-09-13 ~ now
    OF - Director → CIF 0
    OF - Director → CIF 0
    OF - Director → CIF 0
Ceased 1
  • Dr Michael John Davies
    Born in March 1962
    Individual (10 offsprings)
    Person with significant control
    2016-11-08 ~ 2018-07-04
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
    PE - Right to appoint or remove directors with control over the trustees of a trust → CIF 0
    PE - Right to appoint or remove directors as a member of a firm → CIF 0
parent relation
Company in focus

CAROCELL BIO LIMITED

Previous names
BRIDGE BIOTEC LIMITED - 2019-08-14
BRIDGE BIOTEC THERAPEUTICS LIMITED - 2017-02-20
BRIDGE BIOTECH THERAPEUTICS LIMITED - 2016-11-15
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
75000 - Veterinary Activities
86900 - Other Human Health Activities
Brief company account
Intangible Assets
13,957 GBP2023-11-30
17,048 GBP2022-11-30
Property, Plant & Equipment
928 GBP2023-11-30
2,680 GBP2022-11-30
Fixed Assets
14,885 GBP2023-11-30
19,728 GBP2022-11-30
Debtors
6,882 GBP2023-11-30
133,250 GBP2022-11-30
Cash at bank and in hand
6,930 GBP2023-11-30
74,111 GBP2022-11-30
Current Assets
13,812 GBP2023-11-30
207,361 GBP2022-11-30
Creditors
Current
8,960 GBP2023-11-30
19,042 GBP2022-11-30
Net Current Assets/Liabilities
4,852 GBP2023-11-30
188,319 GBP2022-11-30
Total Assets Less Current Liabilities
19,737 GBP2023-11-30
208,047 GBP2022-11-30
Creditors
Non-current
359,969 GBP2023-11-30
338,762 GBP2022-11-30
Net Assets/Liabilities
-340,232 GBP2023-11-30
-130,715 GBP2022-11-30
Equity
Called up share capital
1,215 GBP2023-11-30
1,195 GBP2022-11-30
Share premium
744,262 GBP2023-11-30
666,519 GBP2022-11-30
Retained earnings (accumulated losses)
-1,085,709 GBP2023-11-30
-798,429 GBP2022-11-30
Equity
-340,232 GBP2023-11-30
-130,715 GBP2022-11-30
Average Number of Employees
42022-12-01 ~ 2023-11-30
42021-12-01 ~ 2022-11-30
Intangible Assets - Gross Cost
Other than goodwill
30,903 GBP2022-11-30
Intangible Assets - Accumulated Amortisation & Impairment
Other than goodwill
16,946 GBP2023-11-30
13,855 GBP2022-11-30
Intangible Assets - Increase From Amortisation Charge for Year
Other than goodwill
3,091 GBP2022-12-01 ~ 2023-11-30
Intangible Assets
Other than goodwill
13,957 GBP2023-11-30
17,048 GBP2022-11-30
Property, Plant & Equipment - Gross Cost
Plant and equipment
6,089 GBP2022-11-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
5,161 GBP2023-11-30
3,409 GBP2022-11-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
1,752 GBP2022-12-01 ~ 2023-11-30
Property, Plant & Equipment
Plant and equipment
928 GBP2023-11-30
2,680 GBP2022-11-30
Other Debtors
Amounts falling due within one year, Current
6,882 GBP2023-11-30
133,250 GBP2022-11-30
Bank Borrowings/Overdrafts
Current
4,000 GBP2023-11-30
4,000 GBP2022-11-30
Trade Creditors/Trade Payables
Current
207 GBP2023-11-30
Other Taxation & Social Security Payable
Current
4,746 GBP2022-11-30
Other Creditors
Current
4,753 GBP2023-11-30
10,296 GBP2022-11-30
Bank Borrowings/Overdrafts
Non-current
6,000 GBP2023-11-30
10,000 GBP2022-11-30
Other Creditors
Non-current
353,969 GBP2023-11-30
328,762 GBP2022-11-30
  • CAROCELL BIO LIMITED
    Info
    BRIDGE BIOTEC LIMITED - 2019-08-14
    BRIDGE BIOTEC THERAPEUTICS LIMITED - 2017-02-20
    BRIDGE BIOTECH THERAPEUTICS LIMITED - 2016-11-15
    Registered number 10469714
    London Bioscience Innovation Centre (lbic), 2 Royal College Street, London NW1 0NH
    Private Limited Company incorporated on 2016-11-08 (8 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-07
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.